GoodRx Holdings, Inc. Restructuring and Related Cost, Cost Incurred to Date
GoodRx Holdings, Inc. (GDRX) had Restructuring and Related Cost, Cost Incurred to Date of $7.68 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes
us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 · last filed 2026-02-26
- 2025-12-31: Restructuring and Related Cost, Cost Incurred to Date $7.68M.
- 2024-12-31: Restructuring and Related Cost, Cost Incurred to Date $9.89M.
- 2023-12-31: Restructuring and Related Cost, Cost Incurred to Date $75.15M.
- 2023-09-30: Restructuring and Related Cost, Cost Incurred to Date $40.09M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date |
|---|---|
| 2025-12-31 | $7.68M 10-K · filed 2026-02-26 |
| 2024-12-31 | $9.89M 10-K · filed 2026-02-26 |
| 2023-12-31 | $75.15M 10-K · filed 2026-02-26 |
| 2023-09-30 | $40.09M 10-Q · filed 2023-11-09 |